Patients with increased alanine aminotransferase (ALT) levels and/or dyslipidemia will be assessd for the presence of at least 1 criterion among interstitial lung diseases, growth deceleration or retardation, and HDL-C < 1.1mmol/L (19.8 mg/dl). Here, GPT is linked to metabolic syndrome.